Alerts will be sent to your verified email
Verify EmailSAMYAKINT
Samyak International
|
Rubra Medicaments
|
Lypsa Gems
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
1.23 % | -2.03 % | -27.7 % |
5yr average Equity Multiplier
|
1.43 | 1.44 | 2.37 |
5yr Average Asset Turnover Ratio
|
0.4 | 1.44 | 0.4 |
5yr Avg Net Profit Margin
|
1.7 % | -0.31 % | -132.74 % |
Price to Book
|
0.36 | 35.84 | 1.21 |
P/E
|
0.0 | 223.95 | 0.0 |
5yr Avg Cash Conversion Cycle
|
-79.6 Days | 183.71 Days | 1910.48 Days |
Inventory Days
|
82.16 Days | 0.0 | 17.1 Days |
Days Receivable
|
68.76 Days | 183.71 Days | 3586.85 Days |
Days Payable
|
214.47 Days | 33.56 Days | 2006.22 Days |
5yr Average Interest Coverage Ratio
|
2.64 | -248.31 | 54.4 |
5yr Avg ROCE
|
2.62 % | -2.28 % | -27.35 % |
5yr Avg Operating Profit Margin
|
10.46 % | -0.3 % | -64.99 % |
5 yr average Debt to Equity
|
0.17 | 0.06 | 0.16 |
5yr CAGR Net Profit
|
n/a | 0.0 | n/a |
5yr Average Return on Assets
|
1.0 % | -1.63 % | -13.21 % |
Shareholdings
|
|||
Promoter Holding
|
22.35 % | 0.0 | 36.37 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
13.17 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Samyak International
|
Rubra Medicaments
|
Lypsa Gems
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|